Preview

Cardiovascular Therapy and Prevention

Advanced search

RELATION OF PRO-INFLAMMATORY MARKERS IN MEN AND WOMEN WITH ONE YEAR OUTCOMES AFTER MYOCARDIAL INFARCTION

https://doi.org/10.15829/1728-8800-2015-5-35-39

Abstract

Aim. The evaluation of the prominence of subclinical nonspecific inflammation in men and women with ST-elevation myocardial infarction (STEMI) with different one year outcomes.

Material and methods. Totally 223 patients with STEMI included — 56 (25,1%) women, 167 (74,9%) men. At 10-14 day of hospitalization we checked inflammation factors: interleukins (IL) — 1а, 6, 8, 10, 12, С-reactive protein, tumor necrosis factor, neopterin. In the assessment of inflammatory reaction severity in men and women each group was assessed in general, and further was spread by the age: <65 y.o. and >65 y.o.

Results. In assessment of the combination endpoint it was found that more significantly vascular events developed in women and made up 47% cases, but in men just 33% (р=0,001). Selecting the patients by age-relevant subgroups it was shown that in the age <65 y.o. women had more frequent vascular episodes, than men in this age: 50% (n=20) and 26% (n=89), respectively (р=0,000). In analysis of the IL-12 it is shown than women, comparing to men have this parameter higher in negative as in positive outcome: in positive prognosis 1,4 times higher (р=0,019), and negative prognosis — 1,6 times (р=0,045). In neopterine analysis, depending on combination endpoint it was found than in men with negative outcome the level of neopterin was significantly higher — 17,41 (9,52; 20,90) nmoles/L, than in men with positive outcome — 10,80 (6,53; 10,91) nmoles/L (р=0,000).

Conclusion. Negative prognosis in women with STEMI is associated with the increase of IL-12 by 10-14 day, in men — neopterin. Key words: myocardial infarction, pro-inflammatory markers, gender specifics.

About the Authors

E. V. Tavlueva
FSBSI "Scientific-Research Institute of Complex Cardiovascular Problems". Kemerovo, Russia
Russian Federation


O. L. Barbarash
FSBSI "Scientific-Research Institute of Complex Cardiovascular Problems". Kemerovo, Russia
Russian Federation


References

1. Mueck AO, Seeger H. Smoking, estradiol metabolism and hormone replacement therapy. Curr Med Chem Cardiovasc Hematol Agents 2005; 3 (1): 45-54.

2. Leslee JS, Raffaelle B. Women and Ischemic Heart Disease. JACC 2009; 54: 1561-75.

3. Spence JD, Pilote L. Importance of sex and gender in atherosclerosis and cardiovascular disease. Atherosclerosis 2015; 241(1): 205-7.

4. Roberts WL, Sedrick R, Moulton L, et al. Evaluation of four automated high- sensitive C-reactive protein methods; implications for clinical and epidemiological applications. Clin Chem 2000; 46: 461-8.

5. Tousoulis D, Antoniades C, Stefanadis C. Assessing inflammatory status in cardiovascular disease. Heart 2007; 93: 1001-7.

6. Singh SK, Suresh MV, Voleti B, et al. The connection between C-reactive protein and atherosclerosis. Ann Med 2008; 40(2): 110-20.

7. Martins TB, Anderson JL, Muhlestein JB, et al. Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay. Am J Clin Pathol 2006; 125: 906-13.

8. Fuchs D, Avanzas P, Arroyo-Espliguero R, et al. The role of neopterin in atherogenesis and cardiovascular risk assessment. Curr Med Chem 2009; 16: 4644-53.

9. Ray K, Morrow D, Sabatine AM, et al. Long-term prognostic value of neopterin. A novel marker of monocyte activation in patients with acute coronary syndrome. Circulation 2007; 115: 3071-8.

10. Avanzas P, Arroyo-Espliguero R, Cosin-Sales J, et al. Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease. Am J Cardiol 2004; 93: 627-9.

11. Adachi T, Naruko T, Itoh A, et al. Neopterin is associated with plaque inflammation and destabilisation in human coronary atherosclerotic lesions. Heart 2007; 93: 1537-41.


Review

For citations:


Tavlueva E.V., Barbarash O.L. RELATION OF PRO-INFLAMMATORY MARKERS IN MEN AND WOMEN WITH ONE YEAR OUTCOMES AFTER MYOCARDIAL INFARCTION. Cardiovascular Therapy and Prevention. 2015;14(5):35-39. (In Russ.) https://doi.org/10.15829/1728-8800-2015-5-35-39

Views: 770


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)